ReShape Lifesciences Earnings Estimate
| RSLS Stock | USD 3.18 0.33 11.58% |
ReShape Lifesciences Revenue Breakdown by Earning Segment
By analyzing ReShape Lifesciences' earnings estimates, investors can diagnose different trends across ReShape Lifesciences' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to drop to about 3.4 M in 2025. Pretax Profit Margin is likely to drop to -0.93 in 2025Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ReShape Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
ReShape Lifesciences Earnings Estimation Breakdown
The calculation of ReShape Lifesciences' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of ReShape Lifesciences is estimated to be 0.0 with the future projection ranging from a low of 0.0 to a high of 0.0. Please be aware that this consensus of annual earnings estimates for ReShape Lifesciences is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.00 Lowest | Expected EPS | 0.00 Highest |
ReShape Lifesciences Earnings Projection Consensus
Suppose the current estimates of ReShape Lifesciences' value are higher than the current market price of the ReShape Lifesciences stock. In this case, investors may conclude that ReShape Lifesciences is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and ReShape Lifesciences' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2024 | Current EPS (TTM) | |
| 1 | 0.0% | -3.107 | 0.0 | 264.12 |
ReShape Lifesciences Earnings per Share Projection vs Actual
Actual Earning per Share of ReShape Lifesciences refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering ReShape Lifesciences predict the company's earnings will be in the future. The higher the earnings per share of ReShape Lifesciences, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.ReShape Lifesciences Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as ReShape Lifesciences, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of ReShape Lifesciences should always be considered in relation to other companies to make a more educated investment decision.ReShape Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact ReShape Lifesciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-05-13 | 2025-03-31 | -0.07 | -2.4124 | -2.3424 | 3346 | ||
2024-08-14 | 2024-06-30 | -0.12 | -0.06 | 0.06 | 50 | ||
2024-05-15 | 2024-03-31 | -0.16 | -0.09 | 0.07 | 43 | ||
2024-02-23 | 2023-12-31 | -0.18 | -0.11 | 0.07 | 38 | ||
2023-11-08 | 2023-09-30 | -1.2 | -0.8 | 0.4 | 33 | ||
2023-08-07 | 2023-06-30 | -1.79 | -1.08 | 0.71 | 39 | ||
2023-05-15 | 2023-03-31 | -4.21 | -1.56 | 2.65 | 62 | ||
2023-03-29 | 2022-12-31 | -10 | -8.59 | 1.41 | 14 | ||
2022-11-14 | 2022-09-30 | -17.75 | -26.0 | -8.25 | 46 | ||
2022-08-15 | 2022-06-30 | -18 | -25.0 | -7.0 | 38 | ||
2022-05-23 | 2022-03-31 | -17.25 | -22.0 | -4.75 | 27 | ||
2022-03-28 | 2021-12-31 | -8.75 | -27.0 | -18.25 | 208 | ||
2021-11-11 | 2021-09-30 | -7.5 | -74.0 | -66.5 | 886 | ||
2021-08-16 | 2021-06-30 | -0.22 | -23.5 | -23.28 | 10581 | ||
2021-05-12 | 2021-03-31 | -0.53 | -66.0 | -65.47 | 12352 | ||
2021-03-12 | 2020-12-31 | -9 | -25.5 | -16.5 | 183 | ||
2020-11-06 | 2020-09-30 | -10.5 | -30.0 | -19.5 | 185 | ||
2020-07-30 | 2020-06-30 | -45 | -81.0 | -36.0 | 80 | ||
2020-05-14 | 2020-03-31 | -76.5 | -102.0 | -25.5 | 33 | ||
2020-02-27 | 2019-12-31 | -87 | -96.0 | -9.0 | 10 | ||
2019-11-08 | 2019-09-30 | -321.75 | -91.5 | 230.25 | 71 | ||
2019-07-24 | 2019-06-30 | -365 | -375.0 | -10.0 | 2 | ||
2019-05-10 | 2019-03-31 | -555 | -540.0 | 15.0 | 2 | ||
2019-02-22 | 2018-12-31 | -540 | -585.0 | -45.0 | 8 | ||
2018-11-02 | 2018-09-30 | -715 | -525.0 | 190.0 | 26 | ||
2018-08-02 | 2018-06-30 | -765 | -855.0 | -90.0 | 11 | ||
2018-05-10 | 2018-03-31 | -753.75 | -960.0 | -206.25 | 27 | ||
2018-03-05 | 2017-12-31 | -682.5 | -900.0 | -217.5 | 31 | ||
2017-11-03 | 2017-09-30 | -678 | -825.0 | -147.0 | 21 | ||
2017-08-02 | 2017-06-30 | -656.25 | -690.0 | -33.75 | 5 | ||
2017-05-10 | 2017-03-31 | -618.75 | -705.0 | -86.25 | 13 | ||
2017-02-23 | 2016-12-31 | -510 | -765.0 | -255.0 | 50 | ||
2016-11-11 | 2016-09-30 | -510 | -8190.0 | -7680.0 | 1505 | ||
2016-08-04 | 2016-06-30 | -782.25 | -514.5 | 267.75 | 34 | ||
2016-05-05 | 2016-03-31 | -56 | -65.8 | -9.8 | 17 | ||
2016-02-17 | 2015-12-31 | -63 | -66.5 | -3.5 | 5 | ||
2015-11-09 | 2015-09-30 | -81.9 | -42.0 | 39.9 | 48 | ||
2015-08-06 | 2015-06-30 | -100.8 | -105.0 | -4.2 | 4 | ||
2015-04-30 | 2015-03-31 | -92.4 | -105.0 | -12.6 | 13 | ||
2015-02-18 | 2014-12-31 | -100.8 | -94.5 | 6.3 | 6 | ||
2014-11-12 | 2014-09-30 | -1.44 | -1.2 | 0.24 | 16 | ||
2014-08-07 | 2014-06-30 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2014-04-30 | 2014-03-31 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2014-02-12 | 2013-12-31 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2013-10-31 | 2013-09-30 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2013-07-31 | 2013-06-30 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2013-05-01 | 2013-03-31 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2013-02-13 | 2012-12-31 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2012-10-24 | 2012-09-30 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2012-08-07 | 2012-06-30 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2012-04-24 | 2012-03-31 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2012-01-26 | 2011-12-31 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2011-10-20 | 2011-09-30 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2011-07-21 | 2011-06-30 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2011-04-25 | 2011-03-31 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2011-01-27 | 2010-12-31 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2010-10-21 | 2010-09-30 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2010-07-22 | 2010-06-30 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2010-04-21 | 2010-03-31 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2010-01-28 | 2009-12-31 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2009-10-23 | 2009-09-30 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2009-07-23 | 2009-06-30 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2009-04-23 | 2009-03-31 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2009-01-29 | 2008-12-31 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2008-10-21 | 2008-09-30 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2008-07-24 | 2008-06-30 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2008-04-23 | 2008-03-31 | -999999.9999 | -999999.9999 | 0.0 | 0 | ||
2008-02-20 | 2007-12-31 | -999999.9999 | -999999.9999 | 0.0 | 0 |
About ReShape Lifesciences Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of ReShape Lifesciences earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current ReShape Lifesciences estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as ReShape Lifesciences fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -642.7 M | -610.6 M | |
| Retained Earnings Total Equity | -463.3 M | -486.5 M | |
| Earnings Yield | (0.12) | (0.13) | |
| Price Earnings Ratio | (8.06) | (8.47) | |
| Price Earnings To Growth Ratio | 0.09 | 0.09 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ReShape Stock Analysis
When running ReShape Lifesciences' price analysis, check to measure ReShape Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ReShape Lifesciences is operating at the current time. Most of ReShape Lifesciences' value examination focuses on studying past and present price action to predict the probability of ReShape Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ReShape Lifesciences' price. Additionally, you may evaluate how the addition of ReShape Lifesciences to your portfolios can decrease your overall portfolio volatility.